Search Results - "Seher, Axel"

Refine Results
  1. 1

    Fibroblast Growth Factor Inducible (Fn14)-specific Antibodies Concomitantly Display Signaling Pathway-specific Agonistic and Antagonistic Activity by Salzmann, Steffen, Seher, Axel, Trebing, Johannes, Weisenberger, Daniela, Rosenthal, Alevtina, Siegmund, Daniela, Wajant, Harald

    Published in The Journal of biological chemistry (10-05-2013)
    “…The Fn14-specific monoclonal antibodies PDL192 and P4A8, which are under consideration in clinical trials, showed no agonistic activity with respect to IL8…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Receptor oligomerization and beyond: a case study in bone morphogenetic proteins by Heinecke, Kai, Seher, Axel, Schmitz, Werner, Mueller, Thomas D, Sebald, Walter, Nickel, Joachim

    Published in BMC biology (07-09-2009)
    “…Transforming growth factor (TGF)beta superfamily members transduce signals by oligomerizing two classes of serine/threonine kinase receptors, termed type I and…”
    Get full text
    Journal Article
  4. 4
  5. 5

    HGF-Induced PD-L1 Expression in Head and Neck Cancer: Preclinical and Clinical Findings by Boschert, Verena, Teusch, Jonas, Aljasem, Anwar, Schmucker, Philipp, Klenk, Nicola, Straub, Anton, Bittrich, Max, Seher, Axel, Linz, Christian, Müller-Richter, Urs D A, Hartmann, Stefan

    “…Head and neck squamous cell carcinoma (HNSCC) is a widespread disease with a low survival rate and a high risk of recurrence. Nowadays, immune checkpoint…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Metabolic Fingerprinting of Murine L929 Fibroblasts as a Cell-Based Tumour Suppressor Model System for Methionine Restriction by Schmitz, Werner, Koderer, Corinna, El-Mesery, Mohamed, Gubik, Sebastian, Sampers, Rene, Straub, Anton, Kübler, Alexander Christian, Seher, Axel

    “…Since Otto Warburg reported in 1924 that cancer cells address their increased energy requirement through a massive intake of glucose, the cellular energy level…”
    Get full text
    Journal Article
  10. 10

    Crystal structure analysis reveals a spring-loaded latch as molecular mechanism for GDF-5-type I receptor specificity by Kotzsch, Alexander, Nickel, Joachim, Seher, Axel, Sebald, Walter, Müller, Thomas D

    Published in The EMBO journal (08-04-2009)
    “…Dysregulation of growth and differentiation factor 5 (GDF‐5) signalling, a member of the TGF‐β superfamily, is strongly linked to skeletal malformation…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Utilizing BMP-2 muteins for treatment of multiple myeloma by Seher, Axel, Lagler, Charlotte, Stühmer, Thorsten, Müller-Richter, Urs Dietmar Achim, Kübler, Alexander Christian, Sebald, Walter, Müller, Thomas Dieter, Nickel, Joachim

    Published in PloS one (10-05-2017)
    “…Multiple myeloma (MM) represents a haematological cancer characterized by the pathological hyper proliferation of antibody-producing B-lymphocytes. Patients…”
    Get full text
    Journal Article
  13. 13

    Type I receptor binding of bone morphogenetic protein 6 is dependent on N-glycosylation of the ligand by Saremba, Stefan, Nickel, Joachim, Seher, Axel, Kotzsch, Alexander, Sebald, Walter, Mueller, Thomas D

    Published in The FEBS journal (01-01-2008)
    “…Bone morphogenetic proteins (BMPs), together with transforming growth factor (TGF)-β and activins/inhibins, constitute the TGF-β superfamily of ligands. This…”
    Get full text
    Journal Article
  14. 14

    Low Energy Status under Methionine Restriction Is Essentially Independent of Proliferation or Cell Contact Inhibition by Koderer, Corinna, Schmitz, Werner, Wünsch, Anna Chiara, Balint, Julia, El-Mesery, Mohamed, Volland, Julian Manuel, Hartmann, Stefan, Linz, Christian, Kübler, Alexander Christian, Seher, Axel

    Published in Cells (Basel, Switzerland) (04-02-2022)
    “…Nonlimited proliferation is one of the most striking features of neoplastic cells. The basis of cell division is the sufficient presence of mass (amino acids)…”
    Get full text
    Journal Article
  15. 15

    Structure Analysis of Bone Morphogenetic Protein-2 Type I Receptor Complexes Reveals a Mechanism of Receptor Inactivation in Juvenile Polyposis Syndrome by Kotzsch, Alexander, Nickel, Joachim, Seher, Axel, Heinecke, Kai, van Geersdaele, Laura, Herrmann, Thomas, Sebald, Walter, Mueller, Thomas D.

    Published in The Journal of biological chemistry (29-02-2008)
    “…Bone morphogenetic proteins regulate many developmental processes during embryogenesis as well as tissue homeostasis in the adult. Signaling of bone…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Studies of Binding of Tumor Necrosis Factor (TNF)-like Weak Inducer of Apoptosis (TWEAK) to Fibroblast Growth Factor Inducible 14 (Fn14) by Fick, Andrea, Lang, Isabell, Schäfer, Viktoria, Seher, Axel, Trebing, Johannes, Weisenberger, Daniela, Wajant, Harald

    Published in The Journal of biological chemistry (02-01-2012)
    “…To perform highly sensitive cellular binding studies with TNF-like weak inducer of apoptosis (TWEAK), we developed a bioluminescent variant of soluble TWEAK…”
    Get full text
    Journal Article
  18. 18

    MLN4924 sensitizes monocytes and maturing dendritic cells for TNF‐dependent and ‐independent necroptosis by El‐Mesery, Mohamed, Seher, Axel, Stühmer, Thorsten, Siegmund, Daniela, Wajant, Harald

    Published in British journal of pharmacology (01-03-2015)
    “…Background and Purpose MLN4924 prevents the formation of active cullin‐RING ubiquitin ligase complexes and thus inhibits NF‐κB signalling. Here, we evaluated…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Soluble and transmembrane TNF-like weak inducer of apoptosis differentially activate the classical and noncanonical NF-kappa B pathway by Roos, Claudia, Wicovsky, Andreas, Müller, Nicole, Salzmann, Steffen, Rosenthal, Tina, Kalthoff, Holger, Trauzold, Anna, Seher, Axel, Henkler, Frank, Kneitz, Christian, Wajant, Harald

    Published in The Journal of immunology (1950) (01-08-2010)
    “…TNF-like weak inducer of apoptosis, TWEAK, is a typical member of the TNF ligand family. Thus, it is initially expressed as a type II transmembrane protein…”
    Get full text
    Journal Article